Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

LUNGevity Foundation

April 16, 2020

Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research

By

Upal Basu Roy

Patient Advocacy & Survivorship

Genomic alterations drive more than 60% of adenocarcinoma cases of NSCLC.1 Approximately 25% of these cases will have an oncogenic driver (EGFR, ALK, ROS1, BRAF, or NTRK) that can be […]